TRIB3 and breast carcinoma: TRIB3 has been shown to be induced by both thapsigargin and hypoxia (0.1–0.5% O2) in breast cancer cells and was found to co-localise with Pimonidazole (a marker of hypoxia) in breast cancer tissue.